Get the Stockscreener App
1.39
5.44%
-0.08
After Hours:
1.41
0.02
+1.44%
Treace Medical Concepts Inc stock is traded at $1.39, with a volume of 1.47M.
It is down -5.44% in the last 24 hours and down -31.86% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$1.47
Open:
$1.46
24h Volume:
1.47M
Relative Volume:
1.87
Market Cap:
$88.57M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-1.3598
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-33.81%
1M Performance:
-31.86%
6M Performance:
-80.61%
1Y Performance:
-84.78%
1-Day Range:
$1.355
$1.4999
1-Week Range:
$1.355
$2.20
52-Week Range:
$1.355
$9.0558
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.39 | 93.67M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
111.04 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
370.50 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
93.01 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.99 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.89 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-07-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Market Catalysts: Why is Treace Medical Concepts Inc stock going up2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Treace Medical Concepts Hits New 52-Week Low at $1.58 - Markets Mojo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 Earnings Call Transcript - Insider Monkey
TMCI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Treace Medical Earnings Call Balances Progress and Pressure - TipRanks
Lake Street Capital Issues Pessimistic Forecast for Treace Medical Concepts (NASDAQ:TMCI) Stock Price - MarketBeat
Truist Securities Adjusts Treace Medical Concepts PT to $2 From $3, Maintains Hold Rating - marketscreener.com
Treace Medical net loss hits USD 9.4M in Q4 2025 - Medical Buyer
Treace Medical Concepts, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Treace Medical Concepts Q4 Loss Narrowing Challenges Persistent Bearish Narratives On Profitability - Sahm
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Reveals Potential 100% Upside - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect - ACCESS Newswire
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Is Treace Medical Concepts Inc gaining market shareEarnings Growth Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Treace Medical Concepts Q4 Earnings Call Highlights - MarketBeat
Treace Medical Concepts Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Treace Medical Concepts earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Earnings call transcript: Treace Medical Concepts Q4 2025 reports revenue decline, stock edges up - Investing.com
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
TREACE MEDICAL CONCEPTS, INC. SEC 10-K Report - TradingView
Treace Medical Concepts: Q4 Earnings Snapshot - marketscreener.com
Treace Medical Concepts (NASDAQ: TMCI) posts 2025 loss and guides flat-to-down 2026 sales - Stock Titan
Treace Medical Concepts Q4 Earnings Summary & Key Takeaways - Benzinga
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results - Bluefield Daily Telegraph
Bunion surgery device firm sees 2026 sales flat to down, cash burn halved - Stock Titan
Treace Medical Concepts Q4 2025 Earnings Call Transcript - MarketBeat
Treace Medical Concepts: Fourth Quarter Financial Results Overview - Bitget
Treace Medical Concepts's Earnings: A Preview - Benzinga
Treace Medical Concepts Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Will Treace Medical Concepts Inc. outperform tech stocksJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - mfd.ru
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference - The Globe and Mail
New bunion surgery tools show patients back walking in days - Stock Titan
TMCITreace Medical Concepts, Inc. Latest Stock News & Market Updates - Stock Titan
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to “Hold” at Wall Street Zen - Defense World
Will Treace Medical Concepts Inc. stock attract more institutional investors2025 Market Outlook & Verified High Yield Trade Plans - mfd.ru
Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring a 118.75% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Thursday - MarketBeat
What Catalysts Are Shifting The Narrative For Treace Medical Concepts (TMCI)? - Yahoo Finance
Retail Trends: How much upside does Treace Medical Concepts Inc have2025 Major Catalysts & Weekly Top Gainers Trade List - baoquankhu1.vn
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Armistice Capital and Steven Boyd report 9.99% stake in TREACE MEDICAL (TMCI) - Stock Titan
Treace Medical Concepts (NASDAQ:TMCI) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Treace Medical Concepts to Release Q4 and Full Year 2025 Financial Results - Intellectia AI
Stifel revises Treace Medical Concepts, Inc. (TMCI) price target in sector-wide update - MSN
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 - The Manila Times
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):